Abstract
H3N2 strains of influenza A virus emerged in humans in 1968 and have continued to circulate, evolving in response to human immune pressure. During this process of "antigenic drift," viruses have progressively lost the ability to agglutinate erythrocytes of various species and to replicate efficiently under the established conditions for amplifying clinical isolates and generating vaccine candidates. We have determined the glycome profiles of chicken and guinea pig erythrocytes to gain insights into reduced agglutination properties displayed by drifted strains and show that both chicken and guinea pig erythrocytes contain complex sialylated N-glycans but that they differ with respect to the extent of branching, core fucosylation, and the abundance of poly-N-acetyllactosamine (PL) [-3Galβ1-4GlcNAcβ1-]n structures. We also examined binding of the H3N2 viruses using three different glycan microarrays: the synthetic Consortium for Functional Glycomics array; the defined N-glycan array designed to reveal contributions to binding based on sialic acid linkage type, branched structures, and core modifications; and the human lung shotgun glycan microarray. The results demonstrate that H3N2 viruses have progressively lost their capacity to bind nearly all canonical sialylated receptors other than a selection of biantennary structures and PL structures with or without sialic acid. Significantly, all viruses displayed robust binding to nonsialylated high-mannose phosphorylated glycans, even as the recognition of sialylated structures is decreased through antigenic drift.IMPORTANCE Influenza subtype H3N2 viruses have circulated in humans for over 50 years, continuing to cause annual epidemics. Such viruses have undergone antigenic drift in response to immune pressure, reducing the protective effects of preexisting immunity to previously circulating H3N2 strains. The changes in hemagglutinin (HA) affiliated with drift have implications for the receptor binding properties of these viruses, affecting virus replication in the culture systems commonly used to generate and amplify vaccine strains. Therefore, the antigenic properties of the vaccines may not directly reflect those of the circulating strains from which they were derived, compromising vaccine efficacy. In order to reproducibly provide effective vaccines, it will be critical to understand the interrelationships between binding, antigenicity, and replication properties in different growth substrates.
Highlights
H3N2 strains of influenza A virus emerged in humans in 1968 and have continued to circulate, evolving in response to human immune pressure
As all H3N2 isolates have exhibited drift from the original 1968 introduction of the strain, we have distinguished the subset of drift strains that we studied by analysis of the timed incorporation of receptor binding site (RBS) mutations and the corresponding effects on cell culture and HA titer
Included among the residues that have evolved over the years are several that overlap the receptor binding domain, suggesting that some changes imposed by immune pressure could impact the receptor binding characteristics of the virus
Summary
H3N2 strains of influenza A virus emerged in humans in 1968 and have continued to circulate, evolving in response to human immune pressure During this process of “antigenic drift,” viruses have progressively lost the ability to agglutinate erythrocytes of various species and to replicate efficiently under the established conditions for amplifying clinical isolates and generating vaccine candidates. IMPORTANCE Influenza subtype H3N2 viruses have circulated in humans for over 50 years, continuing to cause annual epidemics Such viruses have undergone antigenic drift in response to immune pressure, reducing the protective effects of preexisting immunity to previously circulating H3N2 strains. Though the 1968 human viruses preferred ␣2,6-linked receptors, they maintained a limited capacity to recognize particular ␣2,3-linked glycans This recognition gradually decreased as H3 strains circulated and adapted to human hosts until 2001, when H3 HAs had lost ␣2,3-Sia recognition altogether [4, 14]. Following the loss of ␣2,3-Sia recognition, H3 subtypes soon exhibited reduced affinity for the prototypical ␣2,6-Sia receptors, namely, short-form glycans terminating in ␣2,6-linked sialic acid, in favor of longer chain structures terminating in ␣2,6-Sia and consisting of multiple N-acetyllactosamine (LacNAc) repeats either on branched structures or as linear extensions [4, 21,22,23]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have